Literature DB >> 28865179

Histopathological challenges in suspected drug-induced liver injury.

David E Kleiner1.   

Abstract

When a patient with suspected drug-induced liver injury (DILI) undergoes liver biopsy, the pathologist is confronted with two major challenges. The first and most important is to establish the pattern(s) of injury which are present. Patterns of injury represent stereotypical responses of an organ to injury and relate to specific aetiologies of liver damage. The pattern of injury and the histological details of that injury can then be analysed with respect to the patient's intercurrent diseases and medication history. The specific expertise of the pathologist can be used to weigh the prospect of DILI against the likelihood of other explanations of injury. The second challenge is to characterize specific types of injury and the severity of injury, both of which may have importance for clinical decision-making and prognosis. The pathologist's report should convey both an accurate description of the pathology as well its interpretation.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acute hepatitis; autoimmune hepatitis; cholestasis; hepatic necrosis; hepatotoxicity

Mesh:

Year:  2017        PMID: 28865179     DOI: 10.1111/liv.13584

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  8 in total

Review 1.  Challenges and Future of Drug-Induced Liver Injury Research-Laboratory Tests.

Authors:  Sabine Weber; Alexander L Gerbes
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

Review 2.  Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.

Authors:  Anil C Anand; Bhaskar Nandi; Subrat K Acharya; Anil Arora; Sethu Babu; Yogesh Batra; Yogesh K Chawla; Abhijit Chowdhury; Ashok Chaoudhuri; Eapen C Eapen; Harshad Devarbhavi; RadhaKrishan Dhiman; Siddhartha Datta Gupta; Ajay Duseja; Dinesh Jothimani; Dharmesh Kapoor; Premashish Kar; Mohamad S Khuroo; Ashish Kumar; Kaushal Madan; Bipadabhanjan Mallick; Rakhi Maiwall; Neelam Mohan; Aabha Nagral; Preetam Nath; Sarat C Panigrahi; Ankush Pawar; Cyriac A Philips; Dibyalochan Prahraj; Pankaj Puri; Amit Rastogi; Vivek A Saraswat; Sanjiv Saigal; Akash Shukla; Shivaram P Singh; Thomas Verghese; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-04-28

Review 3.  Drug-Induced Liver Injury in GI Practice.

Authors:  Naemat Sandhu; Victor Navarro
Journal:  Hepatol Commun       Date:  2020-03-13

4.  The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD/CCL4-induced murine model of liver injury.

Authors:  Shahrbanoo Keshavarz Azizi Raftar; Fatemeh Ashrafian; Sara Abdollahiyan; Abbas Yadegar; Hamid Reza Moradi; Morteza Masoumi; Farzam Vaziri; Arfa Moshiri; Seyed Davar Siadat; Mohammad Reza Zali
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.996

5.  Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury.

Authors:  Ruiyuan Yang; Kexin Li; Cailun Zou; Aileen Wee; Jimin Liu; Liwei Liu; Min Li; Ting Wu; Yu Wang; Zikun Ma; Yan Wang; Jingyi Liu; Ang Huang; Ying Sun; Binxia Chang; Qingsheng Liang; Jidong Jia; Zhengsheng Zou; Xinyan Zhao
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

6.  Osimertinib-related liver injury with successful osimertinib rechallenge: A case report.

Authors:  Yuan-Ling Cheng; Wei-Kuo Chang; Hao Yen; Yi-Jen Peng; Wei-Chou Chang; Ping-Ying Chang
Journal:  Thorac Cancer       Date:  2022-07-06       Impact factor: 3.223

Review 7.  Pathology of autoimmune hepatitis.

Authors:  Claudia Covelli; Diana Sacchi; Samantha Sarcognato; Nora Cazzagon; Federica Grillo; Francesca Baciorri; Daniela Fanni; Matilde Cacciatore; Valeria Maffeis; Maria Guido
Journal:  Pathologica       Date:  2021-06

Review 8.  Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update.

Authors:  Laura Giuseppina Di Pasqua; Marta Cagna; Clarissa Berardo; Mariapia Vairetti; Andrea Ferrigno
Journal:  Biomedicines       Date:  2022-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.